|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy显示文摘Advanced cholangiocarcinoma is associated with poor prognostic survival and has limited therapeutic options available at present. The importance of angiogenesis and expression of pro-angiogenic factors in intrahepatic forms of cholangiocarcinoma suggest that therapies targeting angiogenesis might be useful for the treatment of this disease. Here we report three cases of patients with advanced intrahepatic cholangiocarcinoma progressive after standard chemotherapy and treated with sunitinib 50 mg/d in 6-wk cycles of 4 wk on treatment followed by 2 wk off treatment(Schedule 4/2). In all three patients, sunitinib treatment was associated with a sustained disease control superior to 4 mo, patients achieving either a partial response or stable disease. A reduction in tumor size and density was observed in all cases, suggesting tumor necrosis as a result of sunitinib treatment in these patients. In addition, sunitinib was generally well tolerated and the occurrence of side effects was managed with standard medical interventions, as required. Our results suggest that sunitinib therapy maybe associated with favorable outcomes and tolerability in patients with advanced cholangiocarcinoma. Those observations contributed to launch a prospective phase Ⅱ multicenter trial investigating sunitinib in advanced intrahepatic cholangiocarcinoma(SUN-CK study; NCT01718327). | Chantal Dreyer Marie-Paule Sablin Mohamed Bouattour Cindy Neuzillet Maxime Ronot Safi Dokmak Jacques Belghiti Nathalie Guedj Valérie Paradis Eric Raymond Sandrine Faivre | 2015 | World Journal of Hepatology2015，7，6： | 4 |
| 2 | Stromal expression of SPARC in pancreatic adenocarcinoma显示文摘 | Cindy Neuzillet Annemila? Tijeras-Raballand Jér?me Cros Sandrine Faivre Pascal Hammel Eric Raymond | 2013 | Cancer and Metastasis Reviews (-)2013，，3： | 4 |
| 3 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘 | Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford | 2010 | The Lancet2010，，9742： | 3 |
| 4 | 精神分裂症患者的情感体验和表达(英文)显示文摘背景:精神分裂症存在情感体验和表达障碍。然而,大多数以往研究往往只局限于情感体验(尤其是快感缺乏)或只针对表达。较少有同时研究精神分裂症患者情感体验和表达。目的 :本研究旨在考察精神分裂症患者的快感体验和情感表达。尤其是,特别关注精神分裂症患者的情感障碍(包括快感体验和表达)和阴性症状之间的关系。方法 :150例患者完成了愉快情绪体验量表(Temporal Experience of Pleasure Scale)和情感表达量表(Emotional Expressivity Scale)的评估。结果 :精神分裂症患者表现出快感缺乏,但情感表达的能力完整。以阴性症状为主的精神分裂症患者在期待性愉快体验,尤其是抽象性期待愉快体验上的缺损更为明显结论:研究结果表明,精神分裂症患者存在出快感缺乏,但他们表达情感的能力似乎完好无损。快感缺乏尤以阴性症状为主的精神分裂症患者更为突出。 | Min-yi CHU Xu LI Qin-yu LV Zheng-hui YI Eric F. C. CHEUNG Raymond C. K. CHAN | 2017 | 上海精神医学2017，29，5： | 3 |
| 5 | FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts显示文摘AIM: To evaluate the efficacy and safety of the FOLFIRI regimen in patients with metastatic pancreatic adenocarcinoma (PAC) after the failure of gemcitabine and platinum salts. METHODS: All consecutive patients with histologically confirmed, metastatic PAC and World Health Organiza-tion performance status (PS) ≤ 2 received FOLFIRI-1 [irinotecan 180 mg/m2 on day 1 and leucovorin 400 mg/m2 followed by 5-fluorouracil (5-FU) 400 mg/m2 bolus, then 5-FU 2400 mg/m2 as a 46-h infusion, biweekly] or FOLFIRI-3 (irinotecan 100 mg/m2 on day 1 and leucovorin 400 mg/m2, then 5-FU 2400 mg/m2 as a 46-h infusion and irinotecan 100 mg/m2 repeated on day 3, biweekly) after failure of gemcitabine and platinum-based chemotherapies as a systematic policy in two institutions between January 2005 and May 2010. Tumor response, time to progression (TTP), overall survival rate (OS) and grade 3-4 toxicities were retrospectively studied. Subgroup analyses were performed to search for prognostic factors. RESULTS: Sixty-three patients (52.4% male, median age 59 years) were analyzed. Among them, 42.9% were PS 0, 38.1% were PS 1 and 19.0% were PS 2. Fifty one patients (81.0%) had liver metastases. Before the FOLFIRI regimen, patients had received 1 line (n = 19), 2 lines (n = 39) or 3 lines (n = 5) of chemotherapy. Median TTP obtained with the line before FOLFIRI was 3.9 mo (95% CI: 3.4-5.3 mo). A total of 480 cycles was completed (median: 6 cycles, range: 1-51 cycles). The main reason for discontinuing FOLFIRI was tumor progression (90.3%). Tumor control was achieved in 25 patients (39.7%) (partial response: n = 5, stable disease: n = 20) with FOLFIRI. Median TTP was 3.0 mo (95% CI: 2.1-3.9 mo) and median OS was 6.6 mo (95% CI: 5.3-8.1 mo). Dose adaptation was required in 36 patients (57.1%). Fifteen patients (23.8%) had grade 3-4 toxicities, mainly hematological (n = 11) or digestive (n = 4). Febrile neutropenia occurred in 3 patients. There was no toxic death. PS 2 was significantly associated with poor TTP [hazard ratio (HR): 16.036, P < 0.0001] and OS (HR: 4.003, P = 0.004). CONCLUSION: The FOLFIRI regimen had an acceptable toxicity and an interesting efficacy in our study, limited to patients in good condition (PS 0-1). | Cindy Neuzillet Olivia Hentic Benot Rousseau Vinciane Rebours Léla Bengrine-Lefèvre Franck Bonnetain Philippe Lévy Eric Raymond Philippe Ruszniewski Christophe Louvet Pascal Hammel | 2012 | World Journal of Gastroenterology2012，18，33： | 3 |
| 6 | A family study of endophenotypes for psychosis within an early intervention programme in Hong Kong: Rationale and preliminary findings显示文摘The study of endophenotypes may be a viable strategy to tackle the genetic complexity and phenotypic heterogeneity of psychosis, but this research direction is relatively under-developed in China as compared to Western countries. We have recently initiated one of the first family studies of endophenotypes for psychosis in China. Patients entering an established early psychosis intervention service are recruited into this research project for phenotyping, endophenotyping and genotyping. At the endophenotypic level, four domains (neurological soft signs, neurocognition of prospective memory, social cognition of facial emotion recognition, and affective cognition of anticipatory and consummatory pleasure) are studied in the sample of patients with psychosis and their unaffected siblings. This article illustrates the benefit of a research-oriented clinical programme and its findings based on the data collected as of early 2011. | LUI Simon S Y SHAM Pak CHAN Raymond C K CHEUNG Eric F C | 2011 | Chinese Science Bulletin2011，56，32： | 2 |
| 7 | Low-frequency ultrasound increases non-viral gene transfer to the mouse lung显示文摘如果在 3035 kHz 的范围,低频率的超声(美国) 增加非病毒的基因转移到老鼠肺,学习的目的是估计。美国极大地在空气 / 织物接口由于大精力损失在肺被稀释。低频率的美国的优点,与高周波的美国相比:(i) 增加了成穴(为在房间膜的短暂毛孔的形成负责) 并且(ii ) 在肺穿入期间减少了精力损失。Cationic 类脂化合物 GL67/plasmid DNA (pDNA ) , polyethylenimine (PEI )/pDNA 和裸体 pDNA 经由 intranasal 灌输被交付,动物然后为 10 min 在 0.07 或 0.1 MPa 暴露于美国(sonoporation ) 。在这些条件下面,美国没提高 GL67 或调停 PEI 的 transfection。然而,它确实由约 4 褶层增加了裸体 pDNA 基因转移。重要地,这当 microbubbles 不在时被完成,它是关键的为通常使用高周波(1 MHz ) sonoporation 但是不能在临床上相关的安装承受 nebulization。肺出血也被估计并且出现以一种剂量依赖者方式与美国压力增加。这样,我们证实了低频率的美国能与裸体 pDNA 提高肺基因转移,这改进比更有效以前报导了 1 个 MHz 美国。 | Stefania Xenariou Hai-Dong Liang Uta Griesenbach Jie Zhu Raymond Farley Lucinda Somerton Charanjit Singh Peter K. Jeffery Ronald K. Scheule Seng H. Cheng Duncan M. Geddes Martin Blomley Eric W. F. W. Alton | 2010 | Acta Biochimica et Biophysica Sinica2010，42，1： | 2 |
| 8 | Detection of Left Ventricular Thrombus by Delayed-Enhancement Cardiovascular Magnetic Resonance显示文摘 | Jonathan W. Weinsaft Han W. Kim Dipan J. Shah Igor Klem Anna Lisa Crowley Rhoda Brosnan Olga G. James Manesh R. Patel John Heitner Michele Parker Eric J. Velazquez Charles Steenbergen Robert M. Judd Raymond J. Kim | 2008 | Journal of the American College of Cardiology2008，，2： | 1 |
| 9 | Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib显示文摘 | Maria Serova Armand Gramont Annemila? Tijeras-Raballand Célia Santos Maria Eugenia Riveiro Khemaies Slimane Sandrine Faivre Eric Raymond | 2013 | Cancer Chemotherapy and Pharmacology2013，，5： | 1 |
| 10 | Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors显示文摘 | Baki Topal Joyce Tiek Steffen Fieuws Raymond Aerts Eric Cutsem Tania Roskams Hans Prenen | 2012 | Surgical Endoscopy2012，，8： | 1 |
| 11 | Right Ventricular Dysfunction Assessed by Cardiovascular Magnetic Resonance Imaging Predicts Poor Prognosis Late After Myocardial Infarction显示文摘 | Eric Larose Peter Ganz H. Glenn Reynolds Sharmila Dorbala Marcelo F. Di Carli Kenneth A. Brown Raymond Y. Kwong | 2007 | Journal of the American College of Cardiology2007，，8： | 1 |
| 12 | A 10-kDa Structural Protein of Porcine Reproductive and Respiratory Syndrome Virus Encoded by ORF2b显示文摘 | Wai-Hong Wu Ying Fang Rachel Farwell Melissa Steffen-Bien Raymond R.R Rowland Jane Christopher-Hennings Eric A Nelson | 2001 | Virology2001，，1： | 1 |
| 13 | The role of mega - sports event interest in sponsorship and ambush Marketing attitudes 显示文摘 | Macintosh Eric Raymond | 2012 | Sport Marketing Quarterly2012，，4： | 1 |
| 14 | Developmental changes in Ca2+ currents from newborn rat cardiomyocytes in primary culture显示文摘 | Jean -Pierre Gomez Daniel Potreau Jean -Eric Branka Guy Raymond | 1994 | Pflügers Archiv European Journal of Physiology (-)1994，，3： | 1 |
| 15 | Sunitinib paves the way for targeted therapies in neuroendocrine tumors显示文摘 | Eric Raymond Sandrine Faivre Pascal Hammel Philippe Ruszniewski | 2009 | Targeted Oncology2009，，4： | 1 |
| 16 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘 | Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford | 2010 | The Lancet2010，，9742： | 1 |
| 17 | Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors显示文摘 | Juan W. Valle Sandrine Faivre Richard A. Hubner Enrique Grande Eric Raymond | 2014 | Cancer Treatment Reviews2014，，： | 1 |
| 18 | High- g power sources for the US Army’s HSTSS programme显示文摘 | Lawrence W. Burke Eric S. Irwin Raymond Faulstich Colin E. Newnham Neil Scholey | 1997 | Journal of Power Sources1997，，1： | 1 |
| 19 | 115 W Tm;YAG diode-pumped solid-state laser显示文摘 | Eric C Honea Raymond J Beach seven S Sutton | 1997 | IEEE J Quantum Electronics1997，33，9： | 1 |
| 20 | Heterogeneity in Nsp2 of European-like porcine reproductive and respiratory syndrome viruses isolated in the United States显示文摘 | Ying Fang Dal-Young Kim Susan Ropp Pam Steen Jane Christopher-Hennings Eric A. Nelson Raymond R.R. Rowland | 2004 | Virus Research2004，，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员